ANOVA BLCA result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-04-08 10:28:13 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: BLCA specific
Individual drug analysis: 133
Drug details and screening numbers
Drug Name: Doxorubicin
Drug ID: 133
Synonyms: Doxil,Rubex
Brand name: Adriamycin
Target: DNA intercalating
Number of cell lines screened: 875
Screening concentration range(s): 0.004 to 1.024 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a5 |
TP53_mut |
133 |
1 |
1 |
Doxorubicin |
DNA intercalating |
15 |
4 |
0.0237 |
0.221 |
-2.69 |
-2.91 |
2.3 ** |
2 ** |
2.4 ** |
7.13e-04 |
NA |
NA |
24 |
All-tests volcano plot